education

Marriage, Education, DMT Affect Patients’ Treatment Adherence

Among people with relapsing-remitting multiple sclerosis (RRMS), those who are married and have more formal education are more likely to take treatments as recommended, according to a new study from Iran. The study, “Effects of Disease-Modifying Treatments discontinuation in patients with Relapsing-Remitting Multiple Sclerosis: A 5…

MS-related Fatigue Strongly Affects Youngsters’ Functioning

Multiple sclerosis and its associated fatigue negatively affect school performance, mental health, and physical and social functioning in children and adolescents with the disease, according to a review study. Pediatric-onset multiple sclerosis (POMS) also was associated with negative effects on social functioning, mental health, and quality of life in…

#ACTRIMS2021 – Realities and Challenges of MS in Latin America

Editorā€™s note: TheĀ Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25ā€“27. GoĀ hereĀ to see all the latest stories from the conference. Despite the overall low frequency of cases, multiple sclerosis (MS) in Latin America poses substantial socioeconomic challenges…

MSAA Opens ‘COVID-19 and MS Pathfinder’ Online Informative Platform

The Multiple Sclerosis Association of America (MSAA) teamed withĀ Wondros, a creative production company, to launchĀ COVID-19 and MS Pathfinder, an onlineĀ platform offering theĀ multiple sclerosis (MS) community accurate and regularly updated information to help in safely navigating the COVID-19 pandemic. Topics covered range from managing MS symptoms…

NeurologyLive Launches Series of Educational Videos About MS

NeurologyLiveĀ has launched a series of educational videosĀ intended to provide an overview of the diagnositic methods and treatment options available toĀ multiple sclerosis (MS) patients. The video series, “Advances in the Diagnosis and Management of Multiple Sclerosis,” also will include future perspectives on upcoming MS therapies,…

#ACTRIMS2019 ā€“ Jeffrey Cohen, MD, is New President of ACTRIMS

Jeffrey Cohen, MD, director of the experimental therapeutics program at the Mellen Center for Multiple Sclerosis Treatment and ResearchĀ at the Cleveland Clinic, is the newly named Ā president of ACTRIMS, the Americas Committee for Treatment and Research in Multiple Sclerosis. Cohen’s appointment concluded the 2019 ACTRIMS ForumĀ that ran…

3 Tips for Explaining MS to Others

Face it: Understanding MS isnā€™t easy ā€” even if you have it. Thereā€™s no known cause, no cure, no predictability in progression, and while there are common symptoms and manifestations, they affect everyone differently. Some symptoms come and go with no rhyme or reason and…